Paradoxically, prolonged treatment with AICAR and metformin, two other AMPK activators, has been shown to enhance ERK phosphorylation in melanoma cells by inducing degradation of dual-specificity phosphatase (DUSP) 6 [36]. Here, PRKAA1 is linked to melanoma.